Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 2,562 shares at $59.43 ($152K) on 2025-02-04, disclosed to the SEC on 2025-02-04.
Seasonal sale ($152k) by Chief Technical Officer — this insider has traded RYTM in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.43 | 1,281 | $76K | 50.0% |
| 2 | $59.43 | 1,281 | $76K | 50.0% |
| Total | $59.43 avg | 2,562 | $152K | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |